Europäische Union -
Deutsch -
EMA (European Medicines Agency)
tivicay
viiv healthcare bv - dolutegravir - hiv-infektionen - antivirale mittel zur systemischen anwendung - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
tivicay 50 mg filmtabletten
viiv healthcare gmbh - dolutegravirum - filmtabletten - dolutegravirum 50 mg zu dolutegravirum natricum, excipiens pro compresso dunst. - hiv-1-infektionen - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
tivicay 10 mg filmtabletten
viiv healthcare gmbh - dolutegravirum - filmtabletten - dolutegravirum 10 mg zu dolutegravirum natricum, excipiens pro compresso dunst. - hiv-1-infektionen - synthetika
Schweiz -
Deutsch -
Swissmedic (Swiss Agency for Therapeutic Products)
tivicay 25 mg filmtabletten
viiv healthcare gmbh - dolutegravirum - filmtabletten - dolutegravirum 25 mg zu dolutegravirum natricum, excipiens pro compresso dunst. - hiv-1-infektionen - synthetika